Y
Yichao Zhu
Researcher at Nanjing Medical University
Publications - 40
Citations - 972
Yichao Zhu is an academic researcher from Nanjing Medical University. The author has contributed to research in topics: Medicine & Cell migration. The author has an hindex of 16, co-authored 24 publications receiving 737 citations.
Papers
More filters
Journal ArticleDOI
Dvl2-dependent activation of Daam1 and RhoA regulates Wnt5a-induced breast cancer cell migration.
TL;DR: It is demonstrated for the first time that Wnt5a promotes breast cancer cell migration via Dvl2/Daam1/RhoA through Ectopic expression of dominant negative RhoA or C3 exoenzyme transferase, a Rho inhibitor.
Journal ArticleDOI
Lysophosphatidic Acid Induces MDA-MB-231 Breast Cancer Cells Migration through Activation of PI3K/PAK1/ERK Signaling
TL;DR: The data suggest that ROS generation plays an essential role in the activation of LPA-stimulated PI3K/PAK1/ERK signaling and breast cancer cell migration, and may provide a basis for designing future therapeutic strategy for blocking breast cancer metastasis.
Journal ArticleDOI
PI3K and ERK-induced Rac1 activation mediates hypoxia-induced HIF-1α expression in MCF-7 breast cancer cells.
TL;DR: It is demonstrated that hypoxia-induced HIF-1α expression involves a cascade of signaling events including ROS generation, activation of PI3K and ERK signaling, and subsequent activation of Rac1.
Journal ArticleDOI
PI3K/Akt-dependent phosphorylation of GSK3β and activation of RhoA regulate Wnt5a-induced gastric cancer cell migration.
Jiaojing Liu,Yujie Zhang,Rui Xu,Jun Du,Zhenzhen Hu,Ling Yang,Yongchang Chen,Yichao Zhu,Luo Gu +8 more
TL;DR: It is demonstrated for the first time that Wnt5a promoted gastric cancer cell migration via the PI3K/Akt/GSK3β/RhoA signaling pathway.
Journal ArticleDOI
miR-613 inhibits cell migration and invasion by downregulating Daam1 in triple-negative breast cancer.
Huaping Xiong,Ting Yan,Weijie Zhang,Fangfang Shi,Xuesong Jiang,Xiaohua Wang,Shoushan Li,Ying Chen,Cheng Chen,Yichao Zhu +9 more
TL;DR: MiR-613 weakens the resistance of TNBC cells against paclitaxel rather than adriamycin, cyclophosphamide, docetaxel, and kaempferol and is involved in cell migration and invasion of T NBC cells via targeting Daam1/RhoA signaling pathway.